KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriers
Michaël E. Belloy, Sarah J. Eger, Yann Le Guen, Valerio Napolioni, Kacie Deters, Hyun‐Sik Yang, Marzia A. Scelsi, Tenielle Porter, Sarah‐Naomi James, Andrew Wong, Jonathan M. Schott, Reisa A. Sperling, Simon M. Laws, Elisabeth C. Mormino, Zihuai He, Summer S. Han, André Altmann, Michael D. Greicius
Topics & Concepts
Apolipoprotein EOdds ratioAmyloid (mycology)MedicineInternal medicineAsymptomaticOncologyAlzheimer's diseaseDiseasePathologyEndocrinologyAlzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchFolate and B Vitamins Research